Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05270408 · ClinicalTrials.gov registry record · NA
Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05270408 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 33 participants.
The verdict
NCT05270408, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The research objective of this study is to examine the efficacy of HD-tDCS to the preSMA/DACC region and its influence on verbal episodic memory in patients with MCI or dementia after 10 sessions of HD-tDCS. There will be three treatment arms: two active HD-tDCS (1 mA or 2 mA) and a sham group. A verbal episodic memory task will be completed at baseline, immediately following the last HD-tDCS session, and a 2-month follow-up.
Interventions
- DEVICE Active Transcranial direct current stimulation (STARStim 8)
- DEVICE Sham Transcranial direct current stimulation (STARStim 8)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-07-13 |
| Est. Completion | 2024-02-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05270408
The ClinicalTrials.gov registry entry for NCT05270408 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Transcranial direct current stimulation (STARStim 8) is the first listed.
NCT05270408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05270408 about?
NCT05270408 is a clinical study titled "Noninvasive Brain Stimulation in Mild Cognitive Impairment and Dementia". The research objective of this study is to examine the efficacy of HD-tDCS to the preSMA/DACC region and its influence on verbal episodic memory in patients with MCI or dementia after 10 sessions of HD-tDCS. There will be three treatment arms: two active HD-tDCS (1 mA or 2 mA) and a sham group. A ve...
What is the current status of trial NCT05270408?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-07-13. Estimated completion is 2024-02-15.
What interventions are being tested in trial NCT05270408?
The interventions under investigation include: Active Transcranial direct current stimulation (STARStim 8) (DEVICE), Sham Transcranial direct current stimulation (STARStim 8) (DEVICE).
Who is sponsoring clinical trial NCT05270408?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.